With the macroeconomic recovery worldwide, birth rates have started to improve substantially and are gradually returning to historical levels. Hospitals are again making the nursery and the NICU (neonatal intensive care unit) their priorities. This will result in more capital spending in this area in near future. The trend has just begun, and has a long way to go before any significant reversal. One company that is set to gain from this new trend is Natus Medical (BABY), a global provider of newborn care products. Its shares rose as much as 40% after reporting its third-quarter earnings in October and I feel this is just the beginning.
In this investment thesis I will focus on BABY's...
Only subscribers can access this article, which is part of the PRO research library covering 3,570 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: